Merus (MRUS) 10-Q2022 Q1 Quarterly report

Filed: 9 May 22, 4:06pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: abstract, annum, Article, begun, biweekly, CDPA, Chinese, clarified, Colorado, compliant, composed, conservative, corrective, CPA, CPI, CT, CTA, CTR, dealt, delete, detract, develpo, EC, EDPB, expenditure, fell, flexibility, governor, grace, harder, harmonized, headcount, HHS, highlighting, hoc, hypothetical, imprecise, IND, indefinitely, index, inflationary, MHRA, Overview, paper, Partner, Peto, PHI, portal, premise, proceed, proportionality, reframing, rent, residual, runway, Russia, safest, Science, situation, space, speculative, square, streamline, Supervisor, TBA, theft, thing, threshold, tool, transmit, treasury, Ukraine, unexpected, unsecured, Virginia, watched, XII

Removed: accounted, activated, alkaline, Andrew, anemia, appointed, began, billion, blood, breath, bundling, capitalizing, causality, Cecile, Century, Chamber, closing, cloud, complying, Computing, conclusion, Cosmetic, count, customary, deadline, diarrhea, dispose, disruptive, double, Dr, durable, eased, elevated, Enterprise, equipment, exempt, exercised, expressed, fall, fatigue, FD, FDCA, Febrile, furnished, gather, genomic, geographic, Geuijen, hand, home, hostile, hosting, hypoalbuminemia, Indiana, infusion, integrate, issuer, Joe, Jumpstart, Leerink, lesser, lieu, liver, LLC, lymphocyte, mAb, mouth, neutropenia, occurring, ordered, orderly, participant, phosphatase, pivotal, profit, quorum, rash, recognizing, regulating, remaining, repeal, resignation, resume, resumption, safely, setting, simplified, Sirulnik, skin, solicitation, sore, stacking, Subtopic, supplemental, SVB, tabled, Topic, tumorigenic, unconditional, underpayment, underwriting, vaccination, voluntarily, vomiting, week, white

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

MRUS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Merus N.V. (the “Company”) for the period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 9, 2022

By:

/s/ Sven A. Lundberg

Sven (Bill) Ante Lundberg

President, Chief Executive Officer and

Principal Financial Officer

(Principal Executive Officer and

Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.